Astrana Health's (ASTH) "Hold (C-)" Rating Reiterated at Weiss Ratings

Key Points

• Astrana Health's stock received a "hold (C-)" rating from Weiss Ratings and a downgrade from Zacks Research changing its rating from "strong-buy" to "strong sell."
• The company reported a 34.7% increase in revenue year-over-year, although it missed earnings per share expectations during its last earnings report.
• Astrana Health currently has a market capitalization of $1.72 billion and an average stock price target of $50.50 according to analysts.

Astrana Health (NASDAQ:ASTH - Get Free Report)'s stock had its "hold (c-)" rating restated by stock analysts at Weiss Ratings in a note issued to investors on Wednesday,Weiss Ratings reports.

Separately, Zacks Research lowered shares of Astrana Health from a "strong-buy" rating to a "strong sell" rating in a report on Monday, September 1st. Five investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Astrana Health currently has an average rating of "Hold" and a consensus price target of $50.50.

Astrana Health Price Performance

ASTH stock traded up $0.40 during trading on Wednesday, hitting $30.73. 287,891 shares of the company's stock traded hands, compared to its average volume of 340,935. The business has a fifty day simple moving average of $28.53 and a 200 day simple moving average of $27.85. The stock has a market capitalization of $1.72 billion, a price-to-earnings ratio of 60.26, a P/E/G ratio of 0.72 and a beta of 0.80. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.59 and a current ratio of 1.59. Astrana Health has a 52 week low of $21.20 and a 52 week high of $63.20.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.36 by ($0.17). The firm had revenue of $654.81 million during the quarter, compared to the consensus estimate of $639.13 million. Astrana Health had a return on equity of 3.43% and a net margin of 1.04%.Astrana Health's revenue was up 34.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.40 EPS. Astrana Health has set its Q3 2025 guidance at EPS. As a group, research analysts expect that Astrana Health will post 1.15 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of ASTH. Covestor Ltd grew its position in shares of Astrana Health by 777.6% in the 1st quarter. Covestor Ltd now owns 2,001 shares of the company's stock worth $62,000 after buying an additional 1,773 shares during the last quarter. Tower Research Capital LLC TRC boosted its stake in Astrana Health by 323.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company's stock worth $115,000 after purchasing an additional 3,517 shares in the last quarter. State of Wyoming acquired a new stake in Astrana Health in the 2nd quarter worth approximately $132,000. AlphaQuest LLC boosted its stake in Astrana Health by 144.2% in the 1st quarter. AlphaQuest LLC now owns 4,883 shares of the company's stock worth $151,000 after purchasing an additional 2,883 shares in the last quarter. Finally, US Bancorp DE boosted its stake in Astrana Health by 21.3% in the 1st quarter. US Bancorp DE now owns 5,791 shares of the company's stock worth $180,000 after purchasing an additional 1,015 shares in the last quarter. Hedge funds and other institutional investors own 52.77% of the company's stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.